Therapy News and Research

RSS
Intermediate risk prostate cancer patients can achieve survival benefit with brachytherapy alone

Intermediate risk prostate cancer patients can achieve survival benefit with brachytherapy alone

New ABT approach results in greater weight loss than gold standard treatment, study shows

New ABT approach results in greater weight loss than gold standard treatment, study shows

Increasing adoption of SBRT improves survival rates for older patients with early stage lung cancer

Increasing adoption of SBRT improves survival rates for older patients with early stage lung cancer

Endocrine Society Clinical Practice Guideline recommends CGMs for Type 1 diabetes patients

Endocrine Society Clinical Practice Guideline recommends CGMs for Type 1 diabetes patients

IMRT reduces risk of side effects, improves quality of life for endometrial and cervical cancer patients

IMRT reduces risk of side effects, improves quality of life for endometrial and cervical cancer patients

UCM REACT program receives $2 million federal grant to support children affected by violence

UCM REACT program receives $2 million federal grant to support children affected by violence

CNS experts create new research-based guidelines for evaluation and treatment of NFPAs

CNS experts create new research-based guidelines for evaluation and treatment of NFPAs

UNC secures $18 million NIH funding to form iTech for facilitating HIV research studies

UNC secures $18 million NIH funding to form iTech for facilitating HIV research studies

Research shows degenerative diseases affecting the retina may be treatable with gene therapy

Research shows degenerative diseases affecting the retina may be treatable with gene therapy

Addition of chemotherapy to post-surgical radiation treatment improves survival in medulloblastoma patients

Addition of chemotherapy to post-surgical radiation treatment improves survival in medulloblastoma patients

Specific high-fat diets linked to increased tumor formation in mouse model of intestinal cancer

Specific high-fat diets linked to increased tumor formation in mouse model of intestinal cancer

UHZ cardiologists use innovative catheter technology to repair tricuspid valve

UHZ cardiologists use innovative catheter technology to repair tricuspid valve

University of Bonn researchers develop new method to combat complex brain tumors

University of Bonn researchers develop new method to combat complex brain tumors

Hypofractionated RT can reduce treatment time by half in stage II and III NSCLC patients

Hypofractionated RT can reduce treatment time by half in stage II and III NSCLC patients

SRS reduces likelihood of local recurrence of brain metastases in cancer patients

SRS reduces likelihood of local recurrence of brain metastases in cancer patients

Researchers identify, validate three distinct molecular subtypes of prostate cancer

Researchers identify, validate three distinct molecular subtypes of prostate cancer

Increased use of SBRT linked to improved survival outcomes of NSCLC patients

Increased use of SBRT linked to improved survival outcomes of NSCLC patients

Approval of PD-1 inhibitor scratches surface of potential immunotherapies in recurrent HNSCC

Approval of PD-1 inhibitor scratches surface of potential immunotherapies in recurrent HNSCC

Concord Medical's first proton therapy center to be installed at Beijing Proton Medical Center

Concord Medical's first proton therapy center to be installed at Beijing Proton Medical Center

Qfix launches new Symphony Patient Transport System to safely increase workflow efficiencies

Qfix launches new Symphony Patient Transport System to safely increase workflow efficiencies

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.